Header cover image

Investing Ideas
/
Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

8

0 new

High return on equity, past performance and sound balance sheet.

8 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	688278 Xiamen Amoytop Biotech	CN¥74.32	-3.9%	76.3%	CN¥30.6b	CN¥85.76	PE40.8x	E32.0%	0.6%
	600285 Henan Lingrui Pharmaceutical	CN¥21.65	-3.0%	27.8%	CN¥12.0b	CN¥30.05	PE18x	E16.1%	3.7%
	300896 Imeik Technology DevelopmentLtd	CN¥215.99	-6.9%	-7.1%	CN¥64.9b	CN¥264.74	PE32.1x	E18.2%	0%
	300705 Hunan Jiudian Pharmaceutical	CN¥24.78	-0.5%	24.6%	CN¥12.0b	CN¥33.10	PE24.1x	E25.5%	0.9%
	688578 Shanghai Allist Pharmaceuticals	CN¥56.37	1.4%	52.9%	CN¥22.7b	CN¥75.00	PE19.6x	E18.4%	0.9%
	300573 Shenyang Xingqi PharmaceuticalLtd	CN¥85.79	-9.2%	-19.9%	CN¥15.0b	n/a	PE43.1x	E32.8%	2.4%
	600436 Zhangzhou Pientzehuang Pharmaceutical	CN¥247.10	-1.6%	-4.2%	CN¥149.4b	CN¥277.61	PE48.4x	E15.9%	0.9%
	688506 Sichuan Biokin PharmaceuticalLtd	CN¥199.09	4.6%	86.1%	CN¥72.7b	CN¥226.42	PE21x	E-102.0%	0%

Page 1 of 1